#clinical trials

-Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 monthsAn analysis of ...

-     CROMSOURCE, an international full service contract research organization (CRO), today ...

Grade Recommendation: Strong (Highest)      GREENWICH, Connecticut, Feb. 11, 2013 ...

- PneumRx, Inc., a leader in interventional pulmonology, announced today that University Medical Center Groningen has ...

- Eli Lilly and Company (NYSE: LLY) has released its 2011/2012 Corporate Responsibility Update ...

-     Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com, the leading global aesthetic ...

-     Dainippon Sumitomo Pharma Co., Ltd. ("DSP") (Headquarters: Osaka, Japan) and Takeda ...

- Takeda Global Research and Development (Asia) Pte Ltd (TGRD Asia), a wholly owned subsidiary of Takeda Pharmaceutical ...

- QPS Holdings, LLC, a leading full-service Clinical Research Organization, today announced the launch of its QPS ...

- Resverlogix Corp. (TSX:RVX) today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial ...

Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C ...

- Today ChanTest announces the hiring of Chris Mathes, Ph.D., M.B.A. to lead its business into a new era. Mathes starts ...

- Takeda Global Research and Development Asia, Pte. Ltd. ("TGRD (Asia)") and Takeda Shanghai Development Center ...

- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that the French ...

-     Berg Pharma, a Boston-based pharmaceutical company and the renowned Parkinson's Institute ...